miR-218 promoted the apoptosis of human ovarian carcinoma cells via suppression of the WNT/β-catenin signaling pathway


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅存取

详细

MicroRNA-218 (miR-218) is a short, noncoding RNA, with multiple biological functions. In this study, we aimed to investigate the potential effects of miR-218 on the apoptosis of human ovarian carcinoma cells and the underlying mechanisms by which miR-218 exerted its actions. After over-expressing miR-218 in human ovarian carcinoma (OVCAR3) cells, cell viability was determined by MTT method, cell apoptosis was observed by flow cytometry (FCM), mRNA expression of miR-218, Bcl2, Bax was measured by RT-PCR and protein expression levels of Wnt, tankyrase and β-catenin were quantified by Western blots. Over-expression of miR-218 potently suppressed cell viability and promoted the apoptosis of human ovarian carcinoma cells in a time-dependent manner. In addition, the down-regulation of tankyrase expression level was detected in miR-218-over-expressed cells. Following the block of the Wnt/β-catenin signaling pathway using the inhibitor XAV-939, the effects of miR-218 on the proliferation and apoptosis of human ovarian carcinoma cells were significantly suppressed. Augmenting expression of miR-218 and/or miRNA-218 mimicking therapeutics may provide viable avenue for the treatment of ovarian cancer.

作者简介

Y. Huang

Department of Gynecologic Oncology; Department of Oncology, Shanghai Medical College

Email: hyhuangyan2014@sina.com
中国, Shanghai, 200032; Shanghai, 200032

S.-H. Liang

Department of Gynecologic Oncology; Department of Oncology, Shanghai Medical College

Email: hyhuangyan2014@sina.com
中国, Shanghai, 200032; Shanghai, 200032

L.-B. Xiang

Department of Gynecologic Oncology; Department of Oncology, Shanghai Medical College

Email: hyhuangyan2014@sina.com
中国, Shanghai, 200032; Shanghai, 200032

X.-T. Han

Department of Gynecologic Oncology; Department of Oncology, Shanghai Medical College

Email: hyhuangyan2014@sina.com
中国, Shanghai, 200032; Shanghai, 200032

W. Zhang

Department of Gynecologic Oncology; Department of Oncology, Shanghai Medical College

Email: hyhuangyan2014@sina.com
中国, Shanghai, 200032; Shanghai, 200032

J. Tang

Department of Gynecologic Oncology; Department of Oncology, Shanghai Medical College

Email: hyhuangyan2014@sina.com
中国, Shanghai, 200032; Shanghai, 200032

X.-H. Wu

Department of Gynecologic Oncology; Department of Oncology, Shanghai Medical College

Email: hyhuangyan2014@sina.com
中国, Shanghai, 200032; Shanghai, 200032

M.-Q. Zhang

Department of Gynecologic Oncology; Department of Oncology, Shanghai Medical College

编辑信件的主要联系方式.
Email: hyhuangyan2014@sina.com
中国, Shanghai, 200032; Shanghai, 200032

补充文件

附件文件
动作
1. JATS XML

版权所有 © Pleiades Publishing, Inc., 2017